High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

OncoImmunology

Volumn 6, Issue 1, 2017, Pages

  Sun, Cheng ^a,b   Xu, Jing ^c   Huang, Qiang ^d   Huang, Mei ^d   Wen, Hao ^e   Zhang, Chuanshan ^e   Wang, Jinyu ^a   Song, Jiaxi ^a   Zheng, Meijuan ^f   Sun, Haoyu ^a   Wei, Haiming ^a   Xiao, Weihua ^a   Sun, Rui ^a,b   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d ANHUI PROVINCIAL HOSPITAL   (China)

^e XINJIANG MEDICAL UNIVERSITY   (China)

^f ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; HLA E; NK cells; NKG2A; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; CD200 RECEPTOR; CD56 ANTIGEN; HERMES ANTIGEN; HLA E ANTIGEN; INTERLEUKIN 10; LIGAND; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR NKG2A;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC HEPATITIS B; CLINICAL OUTCOME; DISEASE FREE SURVIVAL; EXHAUSTION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; LIVER TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATURAL KILLER CELL; OVERALL SURVIVAL; PLASMA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR VOLUME; UPREGULATION;

EID: 85021778078     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1264562     Document Type: Article

References (42)

1. Sun C, Sun HY, Xiao WH, Zhang C, Tian ZG. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy. Acta Pharmacol Sin 2015; 36:1191-9; PMID:26073325; http://dx.doi.org/10.1038/aps.2015.41
2. Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H et al. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 2012; 61:427-38; PMID:21930732; http://dx.doi.org/10.1136/gutjnl-2011-300509
3. Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, Shi M, Zhang H, Yang Y, Wu H et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 2008; 129:428-37; PMID:18824414; http://dx. doi.org/10.1016/j.clim.2008.08.012
4. Sun C, Sun H, Zhang C, Tian Z. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma. Cell Mol Immunol 2015; 12:292-302; PMID:25308752; http://dx.doi.org/10.1038/cmi.2014.91
5. Wu Y, Kuang DM, Pan WD, Wan YL, Lao XM, Wang D, Li XF, Zheng L. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 2013; 57:1107-16; PMID:23225218; http://dx.doi. org/10.1002/hep.26192
6. Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009; 50:799-807; PMID:19551844; http://dx.doi.org/10.1002/hep.23054
7. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005; 43:1013-20; PMID:16168521; http://dx.doi.org/10.1016/j.jhep.2005.05.026
8. Koch J, Steinle A, Watzl C, Mandelboim O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol 2013; 34:182-91; PMID:23414611; http://dx.doi.org/10.1016/j.it.2013.01.003
9. Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol 2016; 13:328-36; PMID:26639736; http://dx.doi.org/10.1038/cmi.2015.96
10. Krneta T, Gillgrass A, Chew M, Ashkar AA. The breast tumor microenvironment alters the phenotype and function of natural killer cells. Cell Mol Immunol 2016; 13:628-39; PMID:26277898; http://dx.doi. org/10.1038/cmi.2015.42
11. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480:480-9; PMID:22193102; http://dx.doi.org/10.1038/nature10673
12. Li F, Wei H, Wei H, Gao Y, Xu L, Yin W, Sun R, Tian Z. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 2013; 144:392-401; PMID:23103614; http://dx.doi.org/10.1053/j.gastro.2012.10.039
13. Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004; 173:6072-81; PMID:15528343; http://dx.doi.org/10.4049/jimmunol.173.10.6072
14. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. TGF-beta1 downregulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 2012; 8:e1002594; PMID:22438812; http://dx.doi.org/10.1371/journal.ppat.1002594
15. Kuang DM, Xiao X, Zhao Q, Chen MM, Li XF, Liu RX, Wei Y, Ouyang FZ, Chen DP, Wu Y et al. B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. J Clin Invest 2014; 124:4657-67; PMID:25244097; http://dx.doi.org/10.1172/JCI74381
16. Sun C, Xu J, Song JX, Liu CQ, Wang JY, Weng CC, Sun H, Wei H, Xiao W, Sun R et al. The predictive value of centre tumour CD8(+) T cells in patients with hepatocellular carcinoma: comparison with Immunoscore. Oncotarget 2015; 6:35602-15; PMID:26415232
17. Jin S, Deng Y, Hao JW, Li Y, Liu B, Yu Y, Shi FD, Zhou QH. NK cell phenotypic modulation in lung cancer environment. PLoS One 2014; 9:e109976; PMID:25299645; http://dx.doi.org/10.1371/journal. pone.0109976
18. Benevolo M, Mottolese M, Tremante E, Rollo F, Diodoro MG, Ercolani C, Sperduti I, Lo Monaco E, Cosimelli M, Giacomini P. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med 2011; 9:184; PMID:22032294; http://dx.doi.org/10.1186/1479-5876-9-184
19. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Gonçalves A, André P, Romagné F, Thibault G et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
20. Moser JM, Gibbs J, Jensen PE, Lukacher AE. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol 2002; 3:189-95; PMID:11812997; http://dx.doi.org/10.1038/ni757
21. Gooden M, Lampen M, Jordanova ES, Leffers N, Trimbos JB, van der Burg SH, Nijman H, van Hall T. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8(+) T lymphocytes. Proc Natl Acad Sci USA 2011; 108:10656-61; PMID:21670276; http://dx.doi.org/10.1073/pnas.1100354108
22. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Cancer Res 2005; 65:2921-9; PMID:15805295; http://dx.doi.org/10.1158/0008-5472. C AN-04-2108
23. Carotta S, Targeting NK Cells for anticancer immunotherapy: clinical and preclinical approaches. Front Immunol 2016; 7:152; PMID:27148271; http://dx.doi.org/10.3389/fimmu.2016.00152
24. Chester C, Fritsch K, Kohrt HE. Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy. Front Immunol 2015; 6:601; PMID:26697006; http://dx.doi.org/10.3389/fimmu.2015.00601
25. Ruggeri L, Urbani E, Andre P, Mancusi A, Tosti A, Topini F, Bléry M, Animobono L, Romagné F, Wagtmann N et al. Effects of anti- NKG2A antibody administration on leukemia and normal hematopoietic cells. Haematologica 2016; 101:626-33; PMID:26721894; http://dx.doi.org/10.3324/haematol.2015.135301
26. Guo CL, Yang HC, Yang XH, Cheng W, Dong TX, Zhu WJ, Xu Z, Zhao L. Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma. Asian Pac J Cancer Prev 2012; 13:5909-13; PMID:23317279; http://dx.doi.org/10.7314/APJCP.2012.13.11.5909
27. Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D, Liu Y, Zhu F, Zhang L, Sun W et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010; 52:322-9; PMID:20133006; http://dx.doi.org/10.1016/j.jhep.2009.12.005
28. Meier UC, Owen RE, Taylor E, Worth A, Naoumov N, Willberg C, Tang K, Newton P, Pellegrino P, Williams I et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005; 79:12365-74; PMID:16160163; http://dx.doi.org/10.1128/JVI.79.19.12365-12374.2005
29. Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT et al. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunol Res 2014; 2:1209-19; PMID:25315249; http://dx.doi.org/10.1158/2326-6066.CIR-14-0096
30. Wieten L, Mahaweni NM, Voorter CE, Bos GM, Tilanus MG. Clinical and immunological significance of HLA-E in stem cell transplantation and cancer. Tissue Antigens 2014; 84:523-35; PMID:25413103; http://dx.doi.org/10.1111/tan.12478
31. de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ, Kuppen PJ. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol 2010; 185:7452-9; PMID:21057081; http://dx.doi.org/10.4049/jimmunol.1002629
32. Levy EM, Bianchini M, Von Euw EM, Barrio MM, Bravo AI, Furman D, Domenichini E, Macagno C, Pinsky V, Zucchini C et al. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int J Oncol 2008; 32:633-41; PMID:18292941; http://dx.doi.org/10.3892/ijo.32.3.633
33. Bossard C, Bezieau S, Matysiak-Budnik T, Volteau C, Laboisse CL, Jotereau F, Mosnier JF. HLA-E/beta2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int J Cancer 2012; 131:855-63; PMID:21953582; http://dx.doi.org/10.1002/ijc.26453
34. Zeestraten EC, Reimers MS, Saadatmand S, Goossens-Beumer IJ, Dekker JW, Liefers GJ, van den Elsen PJ, van de Velde CJ, Kuppen PJ. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer 2014; 110:459-68; PMID:24196788; http://dx.doi.org/10.1038/bjc.2013.696
35. Kren L, Slaby O, Muckova K, Lzicarova E, Sova M, Vybihal V, Svoboda T, Fadrus P, Lakomy R, Vanhara P et al. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? Neuropathology 2011; 31:129-34; PMID:20667016; http://dx.doi.org/10.1111/j.1440-1789.2010.01149.x
36. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, Dunn C, Pallant C, Ellis G, Khanna P, Dusheiko G et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010; 6:e1001227; PMID:21187913; http://dx.doi.org/10.1371/journal.ppat.1001227
37. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123:57-65; PMID:17764450; http://dx.doi.org/10.1111/j.1365-2567.2007.02691.x
38. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177:739-47; http://dx.doi.org/10.4049/jimmunol.177.1.739
39. Hu CE, Gan J, Zhang RD, Cheng YR, Huang GJ. Up-regulated myeloid- derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand J Gastroenterol 2011; 46:156-64; PMID:20822377; http://dx.doi.org/10.3109/00365521.2010.516450
40. Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, Schmitt-Knosalla I, Romagnani C. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010; 116:1299-307; PMID:20505160; http://dx.doi.org/10.1182/blood-2009-11-253286
41. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010; 115:2167-76; PMID:19965656; http://dx.doi. org/10.1182/blood-2009-08-238469
42. Moretta L. Dissecting CD56dim human NK cells. Blood 2010; 116:3689-91; PMID:21071612; http://dx.doi.org/10.1182/blood-2010- 09-303057